An overview of the development of past and current drug treatments for obesity in the United States

Yuan Liang

doi:10.1117/12.2669531

24 March 2023 An overview of the development of past and current drug treatments for obesity in the United States

Yuan Liang

Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126114X (2023) https://doi.org/10.1117/12.2669531
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom

Abstract

Obesity is a major public health challenge in the United States. Over one-third of adults in the nation are identified as obese. This research focuses on the past and current status of anti-obesity medications and will thoroughly explore the development and utilization of marketed drugs. The result shows that to date, there are still a limited number of FDA-approved drugs, and their effectiveness remains limited. Despite the complexity of the field of potential drug treatments, the substantial cost, high financial risks, and long duration of clinical research and experiment trials act as barriers to novel drugs. Recent studies suggest that marketed drugs are underused due to the low number of obesity medicine specialists prescribing them and a lack of health insurance coverage for anti-obesity drug treatments. Nonetheless, the benefits of an ideal drug for the treatment of obesity are unquestionable. The urgent need for effective medications with minimal side effects continues to spark discoveries of novel mechanisms and drug treatments.

Citation Download Citation

Yuan Liang "An overview of the development of past and current drug treatments for obesity in the United States", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126114X (24 March 2023); https://doi.org/10.1117/12.2669531

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available